العربية
中国
Français
Deutsch
Ελληνική
हिन्दी
Italiano
日本語
Português
Русский
EspañolSpot Capacity, Risk Distribution and Diversity
Title:
Spot Capacity, Risk Distribution and Diversity
Description:
Open Innovation and the Crowd-Searching Solution Space: Spot Capacity, Risk Distribution and Diversity Alpheus Bingham, founder and former CEO of InnoCentive. BIOGRAPHY Dr. Bingham is a member of the Board and co-founder of InnoCentive, Inc. He has been a strong advocate of open innovation and founded InnoCentive, Inc., along with other ventures that create the advantages of open and networked organizational structures, including: YourEncore, Inc., Coalesix, Inc., Maaguzi, Inc., Indigo Biosystems, Seriosity, Chorus and Collaborative Drug Discovery, Inc. He currently serves on the Board of Directors of Fast Track Systems, Inc., and Collaborative Drug Discovery, Inc.; the advisory boards of the Center for Collective Intelligence (MIT), Phase Forward, Inc., YourEncore, Inc. and Coalesix, Inc. and as a member of the board of trustees of the Bankinter Foundation in Madrid. He has lectured extensively at both national and international events and serves as a Visiting Scholar at the National Center for Supercomputing Application at the University of Illinois at Champaign-Urbana. He is also the former chairman of the Board of Editors of the Research Technology Management Journal. Dr. Bingham was the recipient of the Economist's Fourth Annual Innovation Summit "Business Process Award" for InnoCentive. He was also named as one of Project Management Institute's "Power 50" leaders in October 2005. Dr. Bingham had over 25 years of experience with Eli Lilly and Company in pharmaceutical research and development, research acquisitions and collaborations, portfolio management and R&D strategic planning. Among others, he held positions as Managing Director of the Mont-Saint-Guibert Development Centre, executive director of project and portfolio management, vice-president of sourcing innovation, vice-president of e.Lilly and vice-president of R&D strategy. During his career he was instrumental in creating and developing Eli Lilly's portfolio management process as well as establishing the divisions of Research Acquisitions, the Office of Alliance Management and e.Lilly, a unit for business innovation. Dr. Bingham received a B.S. in chemistry from Brigham Young University and a Ph.D. in organic chemistry from Stanford University.
Author:
citrisuc
Tags:
CITRIS, UCB, Science, Technology, Research,
Spot Capacity, Risk Distribution and Diversity
Description:
Open Innovation and the Crowd-Searching Solution Space: Spot Capacity, Risk Distribution and Diversity Alpheus Bingham, founder and former CEO of InnoCentive. BIOGRAPHY Dr. Bingham is a member of the Board and co-founder of InnoCentive, Inc. He has been a strong advocate of open innovation and founded InnoCentive, Inc., along with other ventures that create the advantages of open and networked organizational structures, including: YourEncore, Inc., Coalesix, Inc., Maaguzi, Inc., Indigo Biosystems, Seriosity, Chorus and Collaborative Drug Discovery, Inc. He currently serves on the Board of Directors of Fast Track Systems, Inc., and Collaborative Drug Discovery, Inc.; the advisory boards of the Center for Collective Intelligence (MIT), Phase Forward, Inc., YourEncore, Inc. and Coalesix, Inc. and as a member of the board of trustees of the Bankinter Foundation in Madrid. He has lectured extensively at both national and international events and serves as a Visiting Scholar at the National Center for Supercomputing Application at the University of Illinois at Champaign-Urbana. He is also the former chairman of the Board of Editors of the Research Technology Management Journal. Dr. Bingham was the recipient of the Economist's Fourth Annual Innovation Summit "Business Process Award" for InnoCentive. He was also named as one of Project Management Institute's "Power 50" leaders in October 2005. Dr. Bingham had over 25 years of experience with Eli Lilly and Company in pharmaceutical research and development, research acquisitions and collaborations, portfolio management and R&D strategic planning. Among others, he held positions as Managing Director of the Mont-Saint-Guibert Development Centre, executive director of project and portfolio management, vice-president of sourcing innovation, vice-president of e.Lilly and vice-president of R&D strategy. During his career he was instrumental in creating and developing Eli Lilly's portfolio management process as well as establishing the divisions of Research Acquisitions, the Office of Alliance Management and e.Lilly, a unit for business innovation. Dr. Bingham received a B.S. in chemistry from Brigham Young University and a Ph.D. in organic chemistry from Stanford University.
Author:
citrisuc
Tags:
CITRIS, UCB, Science, Technology, Research,
Popular searches: Cuba, Scuba Diving, Skydiving, Dubai, Niagara Falls, Rainforest, Surfing, Snowboarding, Sandboarding, Pyramids, Everest, Stonehenge, Bear Grylls
Related Videos:
 | Capacity Planning and Capacity Management Tips Learn tips and tricks on capacity management, capacity planning and optimizing IT in your data center. |
 | Strategic R&D Management executiveeducation.wharton.upenn.edu Whartons Strategic R&D Management program explores the challenges and opportunities R&D leaders face in managing relationships with other business functions, such as manufacturing, marketing, and finance. Led by Wharton faculty, the program helps R&D leaders ensure that the R&D function plays a primary strategic role in their firms larger organizational environment. |
 | The Modern Research Lab "The Modern Research Lab" Prith Banerjee is Senior Vice President of Research at HP and Director of HP Labs, the company's central research organization based in Palo Alto with seven locations worldwide. Most recently, Banerjee was dean of the College of Engineering at the University of Illinois at Chicago. Banerjee is a fellow of the American Association for the Advancement of Science, the Association for Computing Machinery and the Institute of Electrical the Electronics Engineers and a ... |
 | Open Innovation Speaker Series, Linus Dahlander Open Innovation Speaker Series, Linus Dahlander Linus Dahlander will present the following paper this Wednesday which explores the emergence of leadership on open innovation projects. Note, we have posted videos from our past speakers on the website: openinnovation.haas.berkeley.edu PROGRESSING TO THE CENTER: THE ANTECEDENTS AND CONSEQUENCES OF LATERAL AUTHORITY By Linus Dahlander and Siobhan omahony Post-bureaucratic forms of organizing are theorized to rely upon lateral as opposed to ... |
 | Zyprexa Antipsychotics Eli Lilly, Zyprexakills This is a search on google from the past week (20-27.10.2008), One result, This is a documentation of where this link leads you. Here is a link about zyprexakills documents which are being withheld from the public, although having been leaked 2 years ago. Very sad, Very dangerous. If you tolerate this, Then your children will be next. link to the article: alexconstantine.blogspot.com |
 | Pop Science Discovery Science Ident Art Direction: David Bez |
 | HowdyDoIt Hi! We are creating a student version of "Innocentive" for an Entrepreneurship course. The basis of our webpage is for students to share problems (class projects, group work, your own inventions, etc) and have the opportunity to tap into the knowledge base of students around the world by receiving feedback, suggestions, and or help from other students. Now we're taking advantage of "open-source innovation" and asking for YOUR SUGGESTIONS for our project! Please visit the following link for ... |
 | Database Supercomputing on the CM-5 A 1994 promotional video from Thinking Machines corporation describing how the CM-5 massively parallel computer can be applied to database problems |
 | The Art of Chemistry and the Chemistry of Art - Dr. Sasan Karimi March 29, 2006 Dr. Karimi earned his Ph.D. in organic chemistry at the Graduate Center of The City University of New York, preceded with a bachelors degree in chemistry earned from Long Island University. He is a synthetic organic chemist whose scholarly endeavor has led him through the chemistry of natural products containing unusual structures. During his early tenure at Queensborough, Dr. Karimi developed the pedagogy and content for a course in Chemistry and the Arts designed for non ... |
 | Automating and Optimizing Demand Response in Commercial Buil "Automating and Optimizing Demand Response in Commercial Buildings" Mary Ann Piette [Research Director, DR Research Center, LBNL] This talk describes the concept for and lessons from the development and field-testing of an open, interoperable communications infrastructure to support automating demand response (DR). California utilities have been exploring the use of critical peak pricing (CPP) and other DR pricing and program strategies to help reduce peak day summer time electric loads ... |
Popular searches: Cuba, Scuba Diving, Skydiving, Dubai, Niagara Falls, Rainforest, Surfing, Snowboarding, Sandboarding, Pyramids, Everest, Stonehenge, Bear Grylls
